Congress does not have the reputation lately of working for the people. Stalemates between Republicans and Democrats continue to halt progress in both bodies of Congress. However, amidst their inability to seemingly get anything done, 37 members of the Senate
Hall of Shame: Chinese Chicken Jerky Dog Treats and the FDA
January 31, 2013
by Amy Sayre, Paralegal
For years, the U.S. Food and Drug Administration (“FDA”) has been investigating a possible contamination in chicken jerky dog treats. The investigation began in 2007 (on the heels of the massive recall of melamine-tainted pet food in the U.S. and
Take Justice Back is Live
December 05, 2012
by Amy Sayre, Paralegal
The American Association for Justice (“AAJ”) has launched a new online grassroots campaign called Take Justice Back. The site aims to inform consumers about the justice system and the ways in which corporations are using that system to erode their
Hall of Shame: PayPal’s New User Agreement
November 01, 2012
by Amy Sayre, Paralegal
Changes have come to PayPal’s user agreement, and of course, the changes are not for the benefit PayPal’s customers. The company recently added a section to its user agreement which takes away a user’s right to sue in court. PayPal
FDA User Fee Legislation: Lowering Consumer Costs by Increasing the Availability of Generic Drugs on the Market
September 20, 2012
by Corey Raines, Associate
On May 30, 2012, the U.S. House of Representatives passed H.R. 5651 in a 387-5 vote, following Senate approval of corresponding legislation in the process of reauthorizing the FDA Prescription Drug User Fee Act (PDUA). With the current Act expiring
The Nameless and the Powerful
September 20, 2012
by Amy Sayre, Paralegal
A national survey conducted by Findlaw.com recently put focus on most Americans’ lack of knowledge about the Supreme Court. Nearly two-thirds of Americans cannot name one Justice currently serving on the Supreme Court. Not even one. While their names may
GSK Pays for its Past, But What About its Future
July 03, 2012
by Amy Sayre, Paralegal
Federal prosecutors announced Monday a record-breaking $3 Billion settlement with the pharmaceutical giant GlaxoSmithKline (“GSK”). The company, which agreed to plead guilty to criminal charges, is accused of illegally promoting its popular antidepressants Paxil and Wellbutrin as well as failing
The Jury Is Out
June 21, 2012
by Mark Miller, Associate
Observers around the country have been describing the disappearance of the civil jury trial for quite some time. In recent years, fewer than two percent of federal actions have gone to trial and less than one percent were heard by
A Look at CAFA: Seven Years in the Making
June 06, 2012
by Ken Wexler, Founder and Managing Partner
In 2005, Congress passed the Class Action Fairness Act (“CAFA” or the “Act”). The Act was supposedly drafted to prevent class action lawsuit abuse, but it threw the baby out with the bathwater by making it more difficult for all
The Continued Fight to Undo Mensing
May 30, 2012
by Bethany Turke, Associate
Last month, I highlighted the mounting pressure to remedy the inconsistencies and inequities resulting from the Supreme Court’s decision in PLIVA, Inc. v. Mensing, 131 S. Ct. 2567 (2011). In Mensing, the Supreme Court held that generic drug manufacturers cannot
